Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fiorica

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Obstetrics and Gynecology Clinics of North America|January 5, 2002
Prevention and treatment of breast cancerJ Fiorica
Current Opinion in Obstetrics & Gynecology|March 4, 1998
Inherited susceptibility to breast and ovarian cancerT M Diamond, R Sutphen, M Tabano, et al.
Current Opinion in Obstetrics & Gynecology|February 15, 2001
MammographyJ J Bomalaski, M Tabano, L Hooper, et al.
The Journal of Urology|May 1, 1997
The failed anti-incontinence mechanism: a flap valve or cecal wrap for surgical reconstructionP Austin, E Spyropoulos, H Arango, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyL R Bigler, J Tate Thigpen, J A Blessing, et al.
Gynecologic Oncology|April 2, 2002
Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervixJ Fiorica, R Holloway, B Ndubisi, et al.
Gynecologic Oncology|April 1, 1990
Treatment of advanced gynecologic malignancies with intraarterial chemotherapy and accelerated fractionation radiation therapy: a preliminary reportJ P LaPolla, W S Roberts, H Greenberg, et al.
The American Surgeon|January 1, 1993
Natural history and clinical evaluation of the lumpectomy scarC E Cox, H Greenberg, D Fleisher, et al.
British Journal of Cancer|October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumoursI Brana, R Berger, T Golan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Obstetrics and Gynecology Clinics of North America|January 5, 2002
Prevention and treatment of breast cancerJ Fiorica
Current Opinion in Obstetrics & Gynecology|March 4, 1998
Inherited susceptibility to breast and ovarian cancerT M Diamond, R Sutphen, M Tabano, et al.
Current Opinion in Obstetrics & Gynecology|February 15, 2001
MammographyJ J Bomalaski, M Tabano, L Hooper, et al.
The Journal of Urology|May 1, 1997
The failed anti-incontinence mechanism: a flap valve or cecal wrap for surgical reconstructionP Austin, E Spyropoulos, H Arango, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Evaluation of tamoxifen in persistent or recurrent nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyL R Bigler, J Tate Thigpen, J A Blessing, et al.
Gynecologic Oncology|April 2, 2002
Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervixJ Fiorica, R Holloway, B Ndubisi, et al.
Gynecologic Oncology|April 1, 1990
Treatment of advanced gynecologic malignancies with intraarterial chemotherapy and accelerated fractionation radiation therapy: a preliminary reportJ P LaPolla, W S Roberts, H Greenberg, et al.
The American Surgeon|January 1, 1993
Natural history and clinical evaluation of the lumpectomy scarC E Cox, H Greenberg, D Fleisher, et al.
British Journal of Cancer|October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumoursI Brana, R Berger, T Golan, et al.
Pageof 1